Document is current
Any future updates will be listed below
-
Authors
Davide, Arici https://orcid.org/0009-0003-5029-2857
Andrea, Pilotto
Giulia, Pedersoli
Viviana, Cristillo
Irene, Volonghi
Enis, Guso
Francesco, Castelli
Alessandro, Padovani
- License Information
-
More Information
Article History
Received: 9 April 2024
Accepted: 24 October 2024
First Online: 29 October 2024
Declarations
:
: This study received approval from the ethical standards committee on human experimentation (local ethics committee of the ASST Spedali Civili Hospital, Brescia: NP 4067). All methods were carried out in accordance with relevant guidelines and regulations (Declaration of Helsinki).
: Non Applicable.
: Davide Arici none, Andrea Pilotto served on the advisory board of Z-cube (technology division of Zambon pharmaceuticals); he received honoraria from Z-cube s.r.l., Biomarin, Zambon, Abbvie, Nutricia and Chiesi pharmaceuticals. He received research support from Vitaflo Germany and Zambon Italy, Giula Pedersoli none, Irene Volonghi none, Viviana Cristillo none, Enis Guso none, Francesco Castelli none, Alessandro Padovani is consultant and served on the scientific advi-sory board of GE Healthcare, Eli-Lilly and Actelion Ltd. Pharmaceuticals and received speaker honoraria from Nutricia, PIAM, Langstone Technology, GE Healthcare, Lilly, UCB Pharma and Chiesi Pharmaceuticals. He is funded by grant of the Ministry of University (MURST).
